NCT01792804 - Staphylococcus Aureus Bacteremia Antibiotic Treatment Options | Biotech Hunter

Enrollment

215

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 26, 2020

Study Completion Date

March 26, 2020

Conditions

Staphylococcus Aureus Infection

Interventions

DRUG

Trimethoprim-Sulfamethoxazole

study drug 1

DRUG

Clindamycin

study drug 2

DRUG

Linezolid

study drug 3

DRUG

Flucloxacillin

study drug 4

DRUG

Cloxacillin

study drug 5

DRUG

Vancomycin

study drug 6

DRUG

Daptomycin

study drug 7

DRUG

Cefazolin

study drug 8

Trial Locations (40)

1081

VUmc Amsterdam, Amsterdam

5022

Diakonessenhuis Utrecht, Utrecht

9700

UMC Groningen, Groningen

12157

Berlin, Berlin

23562

Lübeck, Lübeck

29107

Quimper, Quimper

30625

Hannover, Hanover

35000

Rennes, Rennes

37000

Tours, Tours

38700

Grenoble, Grenoble

40225

Düsseldorf, Düsseldorf

41071

Sevilla II, Seville

Sevilla, Seville

42800

St. Etienne, Saint-Etienne

44000

Nantes, Nantes

45100

Orléans, Orléans

47805

Krefeld, Krefeld

50935

Uniklinik Köln, Cologne

51375

Leverkusen, Leverkusen

60590

Frankfurt, Frankfurt am Main

73000

Chambéry, Chambéry

74000

Annecy, Annecy

75010

Paris 5, Paris

79106

Freiburg, Freiburg im Breisgau

85000

La Roche-sur-Yon, La Roche-sur-Yon

89081

Ulm, Ulm

92100

Paris 1, Paris

92110

Paris 3, Paris

93000

Paris 2, Paris

94010

Paris 4, Paris

07743

Jena, Jena

1105 AZ

Amsterdam, Amsterdam

4814 CK Breda

Breda, Breda

9700 RB

Groningen, Groningen

5022GC

Tilburg, Tilburg

3584 CX

Utrecht, Utrecht

08035

Barcelona II, Barcelona

08036

Barcelona I, Barcelona

07010

Palma, Palma de Mallorca

NG7 24 H

Nottingham, Nottingham